Sponsored Links
| Baxter Introduces First Ready-to-Use IV Amiodarone |
 |
 |
 |
| Medical News - Cardiovascular and Cardiology | |||
|
Baxter International Inc. (NYSE:BAX) announced today at the American Society of Health-System Pharmacists Summer Meeting and Exhibition that it has launched NEXTERONE® (amiodarone HCl) Premixed Injection, the first and only ready-to-use premixed intravenous (IV) bag version of the antiarrhythmic agent amiodarone in the United States... Read more: Cardiovascular / Cardiology News From Medical News Today
|